Date & Time of Session - 3/2/26 - from 12:00 - 1:00 PM

Overview
Treatment-resistant hypertension is a condition characterized by persistently elevated blood pressure despite the use of multiple antihypertensive agents at optimal doses and is associated with increased cardiovascular risk. In many cases, blood pressure can be controlled with guideline-directed triple therapy, however, a subset of patients continue to have inadequate blood pressure control due to factors such as aldosterone-mediated volume expansion and true pharmacologic resistance. The 2025 hypertension guideline outlines updated recommendations for the evaluation and management of treatment-resistant hypertension, including an emphasis on confirming true resistance and optimizing aldosterone-targeted therapy. With increasing evidence supporting both established mineralocorticoid receptor antagonists and emerging aldosterone synthase inhibitors, it is important to understand when and how these agents may be used and the data supporting their role in therapy. This presentation will review current guideline recommendations and key clinical trials that provide insight into the evolving management of treatment-resistant hypertension.

Objectives
Upon completion of this activity, participants will be able to:
1. Define treatment-resistant hypertension and differentiate it from pseudo-resistance and secondary hypertension. 
2. Summarize key updates from the 2025 hypertension guideline related to the evaluation and management of treatment-resistant hypertension. 
3. Identify the role of aldosterone-targeting therapies, including mineralocorticoid receptor antagonists and aldosterone synthase inhibitors, in treatment-resistant hypertension.

Target Audience
Free 1 credit hour of Continuing Education for St Elizabeth Health Care providers, Pharmacists, Residents and Students

Special Services
If you require special assistance to attend this event, please call Deanna Fliehman at (859) 301-6191

Speaker
Marcella Babatunde, PharmD
PGY1 Pharmacy Resident
St Elizabeth Healthcare - Edgewood, Kentucky

Session date: 
03/02/2026 - 12:00pm EST to 04/30/2026 - 11:59pm EDT
Location: 
St. Elizabeth Healthcare
1 Medical Village Drive
Edgewood, KY 41017
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-9999-26-007-L01-P

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Marcella Babatunde, PharmD

has no relevant financial relationships to disclose at this time.